WEBINAR
Cannabis briefing: Medical marijuana rescheduling is here, now what?
Wednesday, May 13, 2026, at 1-2 p.m. ET
Recent federal action to reclassify state-licensed medical marijuana marks a rapidly developing moment for the cannabis industry. In light of this breaking news, you may be wondering, “How does this impact my business? What do I do now?”
While the announcement signals a meaningful shift in federal posture, key details are still evolving – and many stakeholders are already assessing what this could mean for business planning, investment activity, and compliance priorities.
Join us for a 60-minute webinar briefing focused on separating signal from noise: what is currently known, what remains uncertain, and the practical considerations cannabis companies, investors, and ancillary businesses should be watching as the process unfolds.
In this webinar, we’ll cover:
We hope you’ll join us for this timely conversation as we navigate an industry landscape that is changing in real time.
SPEAKERS
BE AT THE FOREFRONT
"CohnReznick" is the brand name under which CohnReznick LLP and CohnReznick Advisory LLC and their respective subsidiaries provide professional services. CohnReznick LLP and CohnReznick Advisory LLC (and their respective subsidiaries) practice in an alternative practice structure in accordance with the AICPA Code of Professional Conduct and applicable law, regulations, and professional standards. CohnReznick LLP is a licensed CPA firm that provides attest services to its clients. CohnReznick Advisory LLC provides tax and business consulting services to its clients. CohnReznick Advisory LLC and its subsidiaries are not licensed CPA firms.
©2026 CohnReznick Advisory LLC, All Rights Reserved.